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vascular smooth muscle cells in the medial layer due to deposi-Medial artery calcification in ESRD patients is associated with
tion of a matrix-like substance, prior to overt calcification.deposition of bone matrix proteins.
Conclusions. In patients with ESRD undergoing renal trans-Background. In non-ESRD patients, recent studies have dem-
plantation, vascular calcification of the medial layer of theonstrated that the process of vascular calcification resembles
inferior epigastric artery is common (44%), can be detecteddevelopmental osteogenesis. Patients with ESRD are known
by spiral CT, and is associated with deposition of bone matrixto have excessive vascular calcification, but this has previously
proteins. This implies an active cell-mediated process, raisingbeen attributed to the non-cell-mediated process of metastatic
hope that directed intervention can arrest this process.calcification.
Methods. To determine if the calcification observed in pa-
tients with ESRD is related to a cell-mediated process, we re-
moved a piece of inferior epigastric artery at the time of renal Atherosclerotic disease remains a major cause of mor-transplant. Calcium content of the entire vessel was quantified
bidity and mortality in the general population. The assess-with spiral computed tomography (CT). The vessel was then
ment of coronary arteries by new non-invasive imagingexamined histologically for calcification and the presence of
bone matrix proteins by immunohistochemistry, and medial techniques such as electron beam computed tomography
and intimal thickness quantified by histomorphometry. These (EBCT) scan has heightened the awareness that over
findings were correlated with demographic, clinical and labora- 90% of atherosclerotic plaques observed in the aging
tory values.
population are calcified [1]. Furthermore, the magnitudeResults. The proximal inferior epigastric artery was obtained
of calcification by EBCT correlates with the severity offrom 41 patients undergoing renal transplantation, but two
were inadequate for histologic examination. Twenty-seven of obstructive coronary artery disease by angiography [2, 3]
the remaining vessels had no evidence of calcification by Mac- and with clinical cardiac events [3]. Cardiovascular dis-
Neal’s or Alizarin red pH 4.2 staining, five vessels had mild/ ease and stroke are also the leading causes of death in
moderate calcification, and seven had severe calcification, all
patients with end-stage renal disease that require dialysisin the medial layer. Calcification assessed histologically was
(ESRD), at a risk that is 10- to 20-fold the age and sexclosely correlated with calcification score as assessed by spiral
matched general population [4, 5]. Studies evaluatingCT, normalized for vessel weight (P 0.027). Positive immuno-
staining for the bone matrix proteins osteopontin, type I colla- coronary calcification by EBCT in patients with ESRD
gen, bone sialoprotein, and alkaline phosphatase was strongly have demonstrated two- to fivefold more coronary artery
correlated with calcification (all P  0.001), as was a history calcification than age- and sex-matched individuals withof coronary artery disease (P  0.001), and diabetes (P 
angiographically-proven coronary artery disease. Fur-0.034). The calcification score by spiral CT correlated with these
thermore, in a follow-up of these 57 hemodialysis pa-same factors and the serum phosphorus and calcium  phos-
phorus product (P 0.032 and 0.037). The location of immuno- tients, every patient had an increase in their calcification
staining for the bone proteins was strongly associated with the score when followed up just one to two years later [6].
presence of calcification. However, positive immunostaining Goodman et al recently demonstrated this process also
also was observed in association with disorganization of the
affects young adults on dialysis, with a sharp increase in
the magnitude of coronary artery calcification by EBCT
after age 20 [7].Key words: calcium, dialysis, phosphorus, vascular calcification, meta-
static calcification, atherosclerotic disease, extra-skeletal calcification. In dialysis patients, the presence of extra-skeletal calci-
fication has been previously attributed to secondary hy-
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and subsequent deposition in the form of hydroxyapatite. rectly to the transplant recipient. The study was approved
by the Indiana University Purdue University at India-However, several recent studies have not found an asso-
ciation between elevated parathyroid hormone (PTH) napolis/Clarian Institutional Review Board.
and coronary artery calcification [7, 8] or calcification of
Spiral CT scanthe arterioles of the skin in calcific uremic arteriolopathy
(CUA calciphylaxis) [9]. Instead, recent studies evaluat- The arterial specimen was placed in air on a plastic
cup in the center of the CT gantry with the long axis ofing vascular calcification using new techniques in dialysis
patients demonstrate that an elevated serum phospho- the vessel aligned with the long axis of the CT table.
Scanning was performed on the model MX-Twin, (Mar-rus, an elevated serum calcium  phosphorus product,
or increased calcium load are risk factors [7, 9–11]. How- coni Medical Systems, Inc., Cleveland, OH, USA). Data
were acquired with the following parameters: kVP ever, the mechanism by which the elevated concentration
of these ions leads to calcification in dialysis patients is 120; mAs  320; focal spot size  small; gantry rotation
time  1 second; slices/gantry rotation  2; beam colli-unknown. Recent studies in non-dialysis patients have
demonstrated that vascular calcification in coronary ar- mation  2 mm; nominal slice width  1 mm; table
speed  1.5 mm/sec; pitch  0.75 ( 2 slices/rotation).teries of patients with atherosclerosis resembles develop-
mental bone formation, with the production of “bone” Data were reconstructed with the following parameters:
reconstruction field of view  18 cm; matrix  512 proteins by vascular smooth muscle cells, including osteo-
pontin, bone sialoprotein, alkaline phosphatase, and type I 512 pixels; reconstruction algorithm  360 linear; effec-
tive slice width1.1 mm; longitudinal reconstruction in-collagen [12–17]. Recently, we have found evidence of
osteopontin expression at the site of calcification in small crement  0.5 mm; edge enhancement  0%; filter 
standard body (C). Calcium scoring was performed witharterioles in the skin of patients with calcific uremic arte-
riolopathy [9]. This would imply that the deposition of software installed on the scanner console (Marconi Med-
ical Systems). All pixels with density greater than ormineral into vascular tissue in dialysis patients is not sim-
equal to 90 Hounsfield Units (HU) were highlighted inply metastatic, but rather an active process, perhaps par-
(pink) color on the black and white images [18]. A regionalleling that observed in atherosclerotic calcification in
of interest was placed by the operator around all colorednon-dialysis patients. To test the hypothesis that general-
areas of the artery on every image. Calcified lesions wereized vascular calcification in dialysis patients is also cell
defined as those lesions with density equal to or greatermediated, and at least in part regulated by the synthesis
than 90 HU with an area of 0.1 square mm or greaterof these same “bone” matrix proteins by vascular smooth
[18]. Smaller lesions were not scored. A weighting factormuscle cells, we examined arteries obtained from pa-
was applied to each lesion. The weighting factor (F) tients undergoing renal transplantation and compared
(D/100)  0.5, where D is the average density (HU) ofour histologic findings with clinical parameters and labo-
all pixels in each lesion on each image. The score forratory tests.
each lesion was calculated by multiplying the area of
each lesion in square mm by the weighting factor. The
METHODS calcium score for the entire specimen was equal to the
All patients over the age of 18 undergoing a renal sum of the scores for each lesion. In addition, the area
transplant at Indiana University Hospital were eligible was also determined. Small microcentrifuge tubes con-
for the study. At the time of transplant, patients had taining various concentrations of calcium chloride were
sera drawn from their central line prior to the administra- scanned with the same technique described above, estab-
tion of any immunosuppressive medications. During the lishing the linear function of detection at low calcium
transplant procedure, the Transplant Surgeon normally concentration in a sample of comparable size. The spiral
ligates the inferior epigastric artery. For this study, the CT calcification score and area results were divided by
proximal portion of that artery was removed after liga- vessel weight, to normalize for the variation in the size
tion and placed immediately in saline. The vessel was of the vessels.
dissected free of fat and subcutaneous tissue, weighed,
Laboratory valuesand then fixed by placing in 4% paraformaldehyde for 48
hours, followed by 0.25% paraformaldehyde. The vessel The serum collected at the time of transplant was ana-
was taken to the Radiology Department and placed on lyzed for calcium, phosphorus and total alkaline phos-
a dish and moved through a spiral CT scanner (see be- phatase by colorimetric methods using a Roche Auto-
low) to quantify the calcium content. Once analyzed for analzyer (Boehringer Manheim, Indianapolis, IN, USA).
calcium content, the vessel was cut into two pieces and The results for calcium and phosphorus were averaged
embedded in paraffin for sectioning. The patient’s medi- with other values obtained during the hospitalization
cal record was reviewed for demographic, historical, and (prior to transplant, 1 to 3 different measurements), and
the Ca  P product determined by multiplying thesemedication information, supplemented with questions di-
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two values. Serum obtained at the time of transplant also Immunostaining for “bone proteins.” Unstained slides
of tissue sections were deparaffinized in xylene and re-was analyzed by enzyme-linked immunosorbent assay
(ELISA) for intact PTH (IRMA Nichols Institute, San hydrated in descending alcohol. Slides were placed in
3% hydrogen peroxide to inhibit endogenous peroxi-Juan Capistrano, CA, USA) and Bone Specific Alkaline
Phosphatase (Metra Biosystems, Mountain View, CA, dase. After washing in Tris saline, sections were blocked
by 3% bovine serum albumin (Sigma Chemical Co, St.USA). Values for total cholesterol, if available, were
obtained from the patients’ medical record from the pre- Louis, MO, USA) for 15 minutes, and then incubated
in the primary antibody at appropriate dilutions for onevious six months.
hour. The secondary antibody peroxide conjugated goat-
Clinical history anti-rabbit IgG or goat-anti-mouse at 1:400 dilution
(Southern Biotechnology, Birmingham, AL, USA) wasThe medical records were reviewed to determine the
duration of dialysis, type of dialysis (defined as modality applied for 30 minutes, developed with DAB (Vector
Biotechnology, Burlingame, CA, USA), and the sectionin use at the time of transplant), cause of ESRD, pres-
ence or absence of diabetes, history of peripheral vascu- counterstained with Harris Hematoxylin (Sigma). The
antibodies utilized were: anti-osteopontin (1:100), bonelar disease, past history of smoking, and known coronary
artery disease. The latter was defined as stenotic lesions sialoprotein (1:100) and type I collagen (1:50; all gifts
of Larry Fisher, Ph.D., National Institutes of Health).on coronary artery angiogram 30% in any vessel, his-
tory of angioplasty or bypass surgery, or previous myo- CD68, type IV collagen and factor VIII were done with
a DAKO autostainer (with primary antibodies 1:100; allcardial infarction. Medication lists were reviewed for
past or present use of vitamin D, and current use of from DAKO Corp, Carpinteria, CA, USA). Sections of
kidney and/or bone served as positive controls. Staininghormone replacement therapy (women), lipid lowering
agents, anti-hypertensives, and phosphate binders. The without the primary antibody served as a negative con-
trol and was done for each section.phosphate binder calcium intake was calculated by tak-
ing the number of pills per day  the known elemental For the alkaline phosphatase immunostaining, slides
were deparaffinized in xylene and hydrated in gradedcalcium content as defined in the package insert for each
type of calcium containing phosphate binder. alcohols. Endogenous peroxidase activity was quenched
by incubating slides in 1.5% H2O2 in ddH2O, rinsed,
Histologic analysis and incubated in Pepsin Solution (Sigma), rinsed, and
blocked, (ABC Staining System, Santa Cruz, CA, USA).Vessels were stained for the presence of calcification
by MacNeal’s tetrachrome and Alizarin red staining. The Primary antibody (1:500 mouse anti-human placental al-
kaline phosphatase; Chemicon, Temecula, CA, USA)presence or absence of bone matrix proteins was assessed
by immunohistochemistry on paraffin embedded sec- was added for one hour followed by secondary antibody-
biotin and AB enzyme (ABC Staining System). Slidestions after fixation as described above.
MacNeal’s stain. Specimens were deparaffinized in xy- were counterstained with Harris Hematoxylin.
lene and rehydrated in graded alcohol followed by dis-
Histomorphometrytilled water. Sections were then placed in 0.2% silver ni-
trate for 10 minutes in the dark, rinsed, and placed in Histomorphometric measurements were collected on
a Nikon Optiphot II fluorescence microscope (Nikonsodium carbonate-formaldehyde for two minutes. After
rinsing, the sections were placed in Farmer’s diminisher Inc., Garden City, NY, USA) equipped with an Optron-
ics NTSC-CE camera head. Bioquant 98 image analysisfor 30 seconds and rinsed until clear. The sections were
counterstained with tetrachrome solution, rinsed, de- system (R&M Biometrics, Inc., Nashville, TN, USA)
was used to measure section profiles captured using thehydrated and mounted. This stains calcification black,
and non-mineralized collagen and non-collagenous pro- camera head. The following parameters were measured
on sections stained with MacNeal’s stain: vessel and lu-teins (such as unmineralized bone/osteoid) a light blue/
purple color. men area and diameter, and intimal and medial width
(thickness). The results represent the average of mea-Alizarin red stain. Alizarin red is a pH dependent stain,
which can differentiate calcium oxalate from calcium car- surements on 2 to 4 sections per specimen. Sections
where the complete circumference of the vessel was notbonate and phosphate. Calcium oxalate stains reddish-
orange at pH 7 but not at pH 4.2. Calcium carbonate intact, or were tangentially cut, were not quantified.
and calcium phosphate stain reddish-brown at both pHs.
Electron microscopyA 2% aqueous solution of Alizarin red was prepared and
the pH adjusted to 7 or 4.2 with NaOH. Tissue sections One block from one patient was examined by electron
microscopy as previously described [9]. Sections fromwere deparaffinized, incubated with Alizarin red for
three minutes, rinsed with distilled water, and then de- the specimen were deparaffinized in xylene overnight.
They were then immersed in 1% osmium tetraoxide/xylenehydrated through graded alcohol [9].
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for two hours at room temperature. The sections were of ESRD was glomerulonephritis in 15, diabetes mellitus
in ten, polycystic kidney disease in six, genitourinaryrinsed in xylene, followed by propylene oxide and then
placed in 1:1 mixture of propyleneoxide and polybed 812 problems in five, hypertension in three, and unknown
in two patients. These demographics reflect the largeresin for four hours. Specimens were embedded in fresh
resin and polymerized in a 60C oven for 48 hours. Thin percentage of living related transplants and young age
of these patients. Other clinical and laboratory indicessections of the specimens were stained with uranyl ace-
tate and lead citrate and examined with a Phillips CM-10 for the subjects are listed in Table 1.
Inferior epigastric arteries were assessed for the pres-transmission electron microscope (FEI Co., Hillsboro,
OR, USA) operated at 60 kV. ence of calcification by staining with MacNeal’s stain
and Alizarin red as described in the methods. Twenty-
seven vessels had no evidence of calcification (Fig. 1A),
Data analysis five vessels had mild/moderate calcification (Fig. 1B),
Semiquantitative analysis was done for all sections by a seven vessels had severe calcification (Fig. 1C), and two
single reader, who was blinded to patient characteristics. could not be quantified due to inadequate sections. In
Scores for 2 to 6 sections per stain per subject were de- all but one patient, the calcification was located exclu-
termined and averaged. For the histologic calcium con- sively in the medial layer with segmented spots of calcifi-
tent, sections were read for MacNeal’s and were graded cation observed in mild/moderate disease (Fig. 1 B and
from 0 to 4: 0  no calcification (black/silver stain); D, higher magnification of the box in 1B). In severe
1  spots; 2  single segments of black staining; 3  calcification, the calcification was circumferentially lo-
multiple segments; and 4 diffuse, circumferential stain- cated in the media, effectively dissecting the vessel into
ing. A similar grading system was utilized for Alizarin red two pieces (Fig. 1C). There was calcified intimal plaque
(pH 4.2) staining, and the purple-blue staining by Mac- in only one patient, who was diabetic, in addition to
Neal’s stain within the medial layer of the vessel wall. severe medial calcification. The histologic calcification
Histologic calcification score. The histologic calcifica- content was positively correlated with the presence of
tion score was obtained by averaging all of the scores diabetes mellitus (P 0.034) and a history of CAD (P
from all sections for both MacNeal’s and Alizarin red 0.001). No other demographic variable was associated
stains, where a score of1 was labeled “no calcification”; with the histologic calcification content, although those
score of 1 to 2.5mild/moderate calcification; and2.5 patients being treated for hyperlipidemia approached
to 4  severe calcification. The immunohistochemistry significance (P 0.068). No laboratory values correlated
was read in a similar blinded, semiquantitative manner with the histologic calcification content.
with grading of 0 to 4. The calcium score as determined by spiral CT scan,
normalized for the weight of the vessel, was significantlyStatistical analysis. Data are expressed as mean	 SD.
related to the histologic presence of calcification (Ta-Since many of the variables were not normally distrib-
ble 2). The calcification by spiral CT, when assessed byuted, non-parametric statistical methods have been used.
area, reached borderline significance. The calcium scoreSpearman Rank Correlation was used to assess the rela-
and area values were tightly correlated (r  0.92, P tionship between two continuous variables. Relationships
0.001). The serum phosphorus correlated with the cal-between continuous and discrete variables were exam-
cium score by area/weight (r  0.33, P  0.032) and wasined with either the Mann-Whitney U test or Kruskal-
borderline significant for score/weight (r  0.37, P Wallis non-parametric analysis of variance depending on
0.058). Similarly, the Ca  P product was significantlythe number of discrete values. Fisher’s Exact Test was
correlated with both the score/weight (r  0.36, P used when both variables were discrete.
0.037) and the area/weight (r 0.37, P 0.031). Patients
on peritoneal dialysis had greater score/weight (P 
RESULTS 0.012) and area/weight (P  0.014) spiral CT calcium
Forty-one patients entered the study over an eight- content than hemodialysis patients.
month period. Seventeen patients underwent cadaveric On histologic examination, the specimens without cal-
transplants, 19 living related transplants, and three living cification showed a nice linear arrangement of vascular
non-related transplants. The patients were 45	 13 years smooth muscle cells (Fig. 1F). In contrast, the medial
old (range 18 to 64) and had been on dialysis for 25	 20 layer of vessels with calcification showed a haphazard
months (0 to 72). Twenty-five patients were undergoing arrangement of cells, with deposition of a purple staining
hemodialysis at the time of transplantation, 14 were un- material (Fig. 1G). The immunostaining for each of the
dergoing peritoneal dialysis, and two were not yet on four “bone” proteins examined ranged from 0 to 4. The
dialysis. Thirty-one patients were male and ten were positive immunostaining for the bone proteins was al-
female; 35 patients were Caucasian, five were African most exclusively in the media, and generally most promi-
nent in areas adjacent to or surrounding overt calcifica-American and one was an American Indian. The cause
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Table 1. Clinical and laboratory variables of subjects
Variable With/without Mean	SD Range
Diabetes mellitus 14/28
History of CAD 8/33
History of PVDa 2/39
History of hypertensiona 37/3
Ever smoked 12/29
History of hyperlipidemia 10/31
On medication for hyperlipidemia 9/32
On hormone replacementa 3/5 (33 n/a)
On vitamin D therapy 16/25
Body mass index 25.5	4.5 16.1–33.9
Elemental calcium content of phosphate binder mg/day 2247	2095 0–7500
Serum calcium mg/dL 8.9	0.8 6.1–10.2
Serum phosphorus mg/dL 5.2	1.3 2.8–8.2
Serum CaP product mg 2/dL2 46.5	13.1 24.9–71.7
Serum intact PTH pg/mL 452	398 30–1632
Serum total alkaline phosphatase IU 77.6	52.4 19–295
Serum bone specific alkaline phosphatase IU 19.7	21 3.3–117.8
Serum albumin g/L 3.9	0.5 2.5–4.8
Serum total cholesterolb IU 174	56 85–287
Abbreviations are: CAD, coronary artery disease; PVD, peripheral vascular disease; PTH, parathyroid hormone; n/a, not applicable.
a Distribution not suitable for further analysis
b Only available for 29 patients
tion (Fig. 1 H–O), corresponding to areas with the Neal’s stain, 12 (75%) had positive immunostaining
(
1) for at least one bone protein. In contrast, of thehaphazard arrangement of cells and purple staining ma-
terial. The mean 	 SD and (median) immunostaining 11 vessels without positive purple staining, only one (9%)
had positive immunostaining for any bone protein (P score was 1.38 	 1.44 (1.00) for osteopontin, 1.36 	
1.00 (1.00) for bone sialoprotein, 1.46 	 1.25 (1.50) for 0.001). Thus, it appeared that positive immunostaining
was associated with deposition of the purple stainingalkaline phosphatase, and 1.66 	 1.65 (1.00) for type I
collagen. The degree of immunostaining for the bone substance by MacNeal’s stain and could be found in
the absence of calcification as assessed by silver stainproteins was strongly associated with the severity of the
histologic calcification score (Table 2). In vessels with (MacNeal’s) or Alizarin red.
The endothelial layer was intact and positive for Fac-more advanced calcification, there was an apparent loss
of type IV collagen (Fig. 1N) and gain of type I collagen tor VIII in all sections and occasionally thickened. In all
sections, the internal elastic lamina was intact, indicating(Fig. 1O) in the same area, although quantification of
this was not possible. Of the 27 vessels without calcifica- that the medial calcification did not result from encroach-
ment of the intimal layer into the media. There wastion, 16 had evidence of deposition of the purple staining
material in the medial layer by MacNeal’s stain (Fig. 1G). CD68 positive cells (macrophage) in the intima in only
12 sections. CD68  cells were not observed in the me-Of these 16 vessels with positive purple staining by Mac-

Fig. 1. Histologic evaluation of calcified (Ca) and non-calcified (N-Ca) vessels from patients undergoing renal transplantation: Examination of
the arteries revealed a spectrum of calcification changes by MacNeal’s stain from normal appearing vessels (A, non-calcifiedN-Ca;10 objective),
mild/moderate (2) calcification (B, calcified  Ca; 10) and severe (4) medial calcification (C, calcified  Ca; 10). When the area in the
black box in vessel B is examined at higher magnification (20), there is some punctate calcification by MacNeal’s stain (D, arrows) and by
Alizarin red, pH 4.2 (E, arrows). To assess the histologic changes further, we compared a part of the normal vessel (A, black box  N-Ca) to this
area in the 2  Ca vessel (D, black box  Ca) with various stains at higher magnification (40, panels F–O, corresponding to non-calcified (N-Ca)
in A, and the calcified vessel (Ca in D). By MacNeal’s stain, the normal vessel (F, which corresponds to the black box in A) revealed a nice linear
pattern of vascular smooth muscle cells. In contrast, in the minimally calcified area of the moderately calcified vessel (G, corresponding to the
black box in D) revealed a haphazard arrangement of cells, in part, due to the deposition of a purple staining material (arrow in G). Immunostaining
for alkaline phosphatase (-Alk Phosph) revealed minimally positive staining in the uncalcified vessel (H), but positive staining in the calcified
vessel (I, arrow) in an area corresponding to the purple substance in G. Immunostaining for osteopontin (-Osteopontin) revealed a similar
pattern: in the non-calcified vessel (J) there was only scattered positive staining, whereas the staining for osteopontin in the calcified vessel (K,
arrow) was very strong, and appeared to be in the area surrounding cells. Similarly, immunostaining for bone sialoprotein (-BSP) was negative
in the non-calcified vessel (L), but positive in the calcified vessel (M, arrow). It is important to point out that the positive immunostaining for
these bone proteins was in the area with only mild specs of calcium by MacNeal’s stain (D square) and Alizarin red pH 4.2 (E). Thus, the
immunostaining was positive even in the absence of overt calcification. Staining for type IV collagen, a major vascular wall collagen was strong
in all vessels, but there were areas of absent staining for type IV collagen (N, arrow) in calcified vessels. In contrast, staining for type I collagen,
the predominant collagen in bone, was positive in these same areas (O, arrow), suggesting a replacement of type IV collagen with type I collagen.
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Table 2. Relationship of bone protein staining and spiral CT acteristic. The maximum vessel diameter was greatest in
calcification score to histologic calcification content
males compared to females (P  0.049), peritoneal dial-
Histologic calcification ysis versus hemodialysis patients (P  0.039), and older
content age (r 0.36, P 0.041). The maximum lumen diameter
Bone protein None Mild/mod Severe P value was also greater in peritoneal dialysis compared to hemo-
Number vessels 27 5 7 dialysis patients (P  0.001), and negatively correlated
Osteopontina 0.5 2.5 4.0 0.001 with the calcium load from phosphate binders (r 
Alkaline phosphatasea 0.5 2.0 3.0 0.001
0.041, P  0.023). The maximum vessel and lumenBone sialoproteina 0.5 1.5 3.5 0.001
Type I collagena 0.5 2.0 4.0 0.001 diameter were strongly correlated with the maximum
Spiral CT score/weightb mg 0.067 0.020 1.061 0.027 medial thickness (r  0.68, P  0.001 and r  0.54,
Calcification area/weightb mg 0.073 0.040 0.288 0.078
P  0.001, respectively). Not surprisingly, the maximum
a Sections were scored semiquantitatively from 0 (no staining) to 4 (staining
vessel diameter correlated with the maximum lumen di-diffusely in nearly all of vessel). Results are the median staining score for vessels
in each of the three calcification score categories. ameter (r  0.84, P  0.001).
b Vessels, prior to sectioning were weighed and then analyzed by spiral CT
Electron micrographs revealed the presence of matrixscanner for presence of calcification (see Methods)
vesicles adjacent to the collagen fibrils, similar to those
we observed with calcific uremic arteriolopathy [9].
dial layer even with advanced medial calcinosis. A his-
DISCUSSIONtory of coronary artery disease was associated with posi-
The results of this study in patients with ESRD demon-tive immunostaining of osteopontin (P  0.001), type I
strate that calcification of the inferior epigastric arterycollagen (P  0.015), alkaline phosphatase (P  0.008)
is in the form of medial calcinosis. In addition, for theand bone sialoprotein (P 0.092). Similarly, vessels from
first time in dialysis patients to our knowledge, we havepatients with diabetes, compared to non-diabetics, was
demonstrated that this calcification is associated withassociated with positive immunostaining for osteopontin
expression of “bone” matrix proteins, similar to findings(P  0.001), type I collagen (P  0.012), and alkaline
in vessels of non-dialysis patients with both atheroscle-phosphatase (P  0.015). Increasing age correlated with
rotic coronary arteries [12–16] and small distal vesselsalkaline phosphatase immunostaining (r  0.40; P 
in medial calcinosis [17]. The presence of positive immu-0.015). Increasing body mass index correlated with im-
nostaining for these bone proteins was found more fre-munostaining for both alkaline phosphatase (r  0.43,
quently than was overt calcification, which suggests thatP  0.008) and bone sialoprotein (r  0.34; P  0.039).
the deposition of these proteins precedes calcification.The relationship of laboratory values and immunostain-
Furthermore, in vessels without histologic evidence ofing was not consistent for the different proteins. How-
calcification but positive immunostaining for these boneever, there was a significant negative correlation of type I
matrix proteins, there was a deposition of purple-staincollagen immunostaining and serum calcium phospho-
rus product (r  0.34, P  0.043) and serum calcium material in the same location in the medial layer of the
arteries. In bone biopsies using a MacNeal’s stain, thislevel (r0.42, P 0.010); alkaline phosphatase immu-
nostaining with serum phosphorus (r  0.41, P  purple staining correlates with deposition of osteoid, or
unmineralized bone, composed of collagen and non-0.012); and bone sialoprotein immunostaining with se-
rum bone alkaline phosphatase (r  0.41, P  0.012). collagenous proteins. Thus, our findings suggest that the
initial changes that occur in the vessels of dialysis patientsThe vessels that were histologically intact (N  32)
were analyzed by histomorphometry. The maximum inti- are the deposition of these bone matrix proteins, fol-
lowed by calcification. However, a single time point studymal width/thickness was 0.059 	 0.072 mm (range 0 to
0.246 mm). The maximum medial width was 0.372 	 such as this cannot truly assess the order in which this
process occurs. Nevertheless, these histologic changes0.117 mm (0.201 to 0.658 mm). The maximum vessel
diameter was 2.21 	 0.71 mm (1.07 to 3.98 mm). The observed in the arteries of ESRD patients clearly parallel
observations in bone.maximum lumen diameter was 1.48 	 0.57 mm (0.45 to
3.16 mm). In the vessels with severe (4) calcification, Calcification in bone proceeds as a tightly regulated
process. Osteoblasts produce matrix, most predomi-the vessel wall was so disrupted that morphometric anal-
ysis could not be done. The maximum intimal thickness nantly type I collagen, which is subsequently mineralized
by the ordered deposition of hydroxyapatite on to thecorrelated with the presence of diabetes (P  0.005),
African American race (P 0.016), the duration of dial- collagen and matrix lattice [19]. The hydroxyapatite is
believed to form in the osteoblast and is concentratedysis (r  0.38, P 0.030) and the calcium load (r  0.39,
P 0.030). The maximum medial thickness was greatest in cell membrane vesicles. These vesicles then pinch off
from the cell membrane to form matrix vesicles, whichin males compared to females (P  0.004), but did not
correlate with any other laboratory or demographic char- attach to the type I collagen fibrils and other non-collage-
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nous matrix proteins [20]. Numerous cytokines and hor- (calciphylaxis) [9], carotid and aortic calcification [11, 26],
and hemodynamic abnormalities [10]. In addition, Blockmones are known to regulate this process in bone. In
the present study, we were able to demonstrate a replace- et al have recently found elevated phosphorus and
calcium  phosphorus product were associated with in-ment of type IV collagen, found in blood vessels, with
type I collagen, predominately found in bone (Fig. 1 N, creased mortality [27], principally due to cardiovascular
death (abstract; Hafeez et al, J Am Soc Nephrol 10:282A,O). Watson et al have previously demonstrated that bo-
vine vascular smooth muscle cell isolates that rapidly 1999). These studies suggest a relationship of these labo-
ratory values and positive calcium and phosphorus bal-mineralized in vitro produced three times the type I
collagen, and markedly less type IV collagen than cells ance with vascular disease. The present study was able to
demonstrate that the serum phosphorus and calcium that did not mineralize [21]. In addition, we observed
the presence of matrix vesicles by electron micrographs. phosphorus product correlated with the calcification
score of inferior epigastric artery as assessed by spiralThese findings imply that an active cell-mediated process
of mineralization exists in vascular tissue, similar to that CT. However, we were unable to demonstrate a clear
relationship with serum values and immunostaining ofin bone.
In atherosclerotic disease, the calcification is felt to these bone proteins, and in fact, the only significant rela-
tionships were actually inverse. The reasons for thesebe a late phenomenon after initial plaque formation in
response to atherosclerotic risk factors such as lipid oxi- inconsistent findings is unclear, but may be due to the
fact that we were only able to assess values of calciumdation, macrophage infiltration and inflammation. In the
present study, we were unable to find any evidence of and phosphorus at the time of transplantation due to
the large referral base for our transplant program. Thesemacrophages or other cellular infiltrates in the medial
calcification, which implies that an inflammatory process single values may not reflect previous calcium and phos-
phorus balance, may be falsely low due to an alteredis not a requirement for calcification of the vascular
smooth muscle cells. Despite past thoughts that medial dialysis schedule in the immediate pre-transplant period,
and/or reflect increased attention to dietary factors andcalcification and atherosclerotic/plaque calcification are
mechanistically distinct, thus far, there is no evidence changes in binder therapy in response to known vascular
disease. Clearly, longitudinal clinical studies and moreto support this hypothesis. However, it is possible that
different factors lead to similar cellular events in these in vitro work is needed to fully understand this process
and demonstrate a true cause effect of hyperphosphate-two forms of calcification, up-regulating specific genes
and transcription factors important in the calcification mia, calcium phosphorus product, and/or calcium load
on the induction of vascular calcification.process. In vitro studies have demonstrated in vascular
smooth muscle cells that the expression of these genes In dialysis patients, calcification of the coronary arter-
ies and aorta have been assessed by new imaging meth-and transcription factors proceed in a sequence similar to
that in bone [14, 16, 17, 22]. Indeed, cultures of vascular ods such as EBCT [6, 7] and spiral CT (abstract; Ahmed
et al, J Am Soc Nephrol 11:552A, 2000). Results in dial-smooth muscle cells can be induced to form bone-like
nodules in the presence of calcification media, consisting ysis patients have revealed markedly greater calcification
scores of the coronary arteries than non-dialysis patientsprimarily of -glycerophosphate, as a phosphorus donor
[12, 23, 24] similar to that observed in osteoblasts in with documented severe three-vessel atherosclerotic cor-
onary artery disease [6]. We found in the ex vivo tissue thatculture [25].
What makes this process so prominent in dialysis pa- medial calcification observed by histology was strongly
correlated with that detected by spiral CT. Thus, onetients? Dialysis patients are known to have many vascu-
lar risk factors such as a history of cardiac disease, diabe- potential explanation for these astronomical scores ob-
served clinically in the coronary arteries of dialysis pa-tes, oxidized lipids, and hypertension. In the present study
a history of coronary artery disease and diabetes were tients is the presence of significant calcification in the
medial layer, in addition to that observed in atheroscle-correlated with calcification by both histology and spiral
CT, and correlated with bone protein immunostaining, rotic plaques. However, the present study evaluated the
inferior epigastric artery, and it is possible that the loca-albeit weakly. Advancing age and increased body mass
index also appear to be contributing factors, as has been tion of calcification in coronary arteries is different. In
the vessels taken from transplant recipients, the medialfound in vascular disease in non-dialysis patients.
In addition to these traditional vascular risk factors, thickness was increased, whereas the intimal thickness
was decreased, when compared to a published morpho-there is increasing evidence that elevated serum phos-
phorus, serum calcium  phosphorus product, and/or metric evaluation of the same vessels in non-dialysis
patients undergoing cardiac revascularization [28]. Fur-calcium load in the form of calcium containing phosphate
binders are associated with various vascular end-points thermore, calcification was uncommon in the inferior
epigastric artery of these non-dialysis patients, evenincluding coronary artery calcification by electron beam
computed tomography [7], calcific uremic arteriolopathy though they had coronary artery disease of a magnitude
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requiring surgery [28]. Schwartz et al, in examining coro- esize that the uremic state leads to the deposition of
nary arteries from autopsy sections, did not find a differ- these bone proteins, with subsequent calcification, per-
ence in the number and size of atherosclerotic plaques haps accelerated, in the presence of the positive calcium
between non-ESRD patients and ESRD patients, but and phosphorus balance so common in ESRD patients.
did find that ESRD patients had a thickened medial Confirming this hypothesis and determining what fac-
layer. Calcification was more common in the ESRD pa- tor(s) in uremia contribute to the initial changes will
tients in the atherosclerotic plaques compared to non- require further study. However, the findings of an active
dialysis patients, and medial calcification was only found process lend hope to the possibility of interventions to
in the medial layer of ESRD patients [29]. The presence stop, or even reverse, the calcification process in patients
of predominately medial calcification in the present with end-stage renal disease.
study parallels earlier reports [30, 31]. However, none
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